Cited by 2,222Cancer Cells and MetastasisCellular Mechanics and InteractionsLymphatic System and Diseases

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, Carl-Henrik, Rubin, Kristofer, Pietras, Kristian, Östman, Arne·2004·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

Many solid tumours show an increased interstitial fluid pressure (IFP), which forms a barrier to transcapillary transport. This barrier is an obstacle in tumour treatment, as it results in inefficient uptake of therapeutic agents. There are a number of factors that contribute to increased IFP in the tumour, such as vessel abnormalities, fibrosis and contraction of the interstitial matrix. Lowering the tumour IFP with specific signal-transduction antagonists might be a useful approach to improving anticancer drug efficacy.

Integrity signals

Registry

Crossref · 10.1038/nrc1456

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Bałuk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 987
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D. J., Wain, J. R., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 982

Flagged first, then by citations

Show all 78 references

Research works printed but not linked: 1

Kristensen, C. A. et al. Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts. Br. J. Cancer 74, 533–536 (1996). · DOI

Sorted by citations

Items 401–500 of 1,003

Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma
Oldberg, Å., Kalamajski, S., Salnikov, A. V., Stuhr, L. E. B., Mörgelin, M., Reed, R. K., Heldin, N., & Rubin, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702014104 · Cited by 95
Self-citation
The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor β Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting of Both Structures by Small Molecules To Downregulate Gene Expression
Brown, R. V., Wang, T., Chappeta, V. R., Wu, G., Onel, B., Chawla, R., Quijada, H., Camp, S. M., Chiang, E. T., Lassiter, Q. R., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10028 · Cited by 95
Cell Volume Regulation in Epithelial Physiology and Cancer
Pedersen, S. F., Hoffmann, E. K., & Novak, I. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00233 · Cited by 94
Therapeutic applications of aptamers
Kaur, G., & Roy, I. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.1.43 · Cited by 95
Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment
Li, T., Li, K., Wang, C., Liu, X. Z., Wen, Y., Xu, Y., Zhang, Q., Zhao, Q.-Y., Shao, M., Li, Y.-Z., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.024 · Cited by 96
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Wu, P., Han, J., Gong, Y., Liu, C., Yu, H., & Xie, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101990 · Cited by 99
Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours
Yim, H., Park, S.-J., Bae, Y. H., & Na, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.058 · Cited by 95
Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments
Ham, I., Lee, D., & Hur, H. (2019) · Journal of Oncology · doi:10.1155/2019/6270784 · Cited by 94
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 103
Nucleic acid aptamers for target validation and therapeutic applications.
Pendergrast, P. S., Marsh, H. N., Grate, D., Healy, J. M., & Stanton, M. J. (2005) · PubMed Central · Cited by 93
Forkhead Box F1 Regulates Tumor-Promoting Properties of Cancer-Associated Fibroblasts in Lung Cancer
Saito, R.-A., Micke, P., Paulsson, J., Augsten, M., Peña, C., Jönsson, P., Botling, J., Edlund, K., Johansson, L., Carlsson, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3644 · Cited by 93
Self-citation
Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy
Su, Y., Fang, J., Liao, C.-Y., Lin, C.-T., Li, Y.-T., & Hu, S. (2015) · Theranostics · doi:10.7150/thno.12843 · Cited by 92
Multiscale homogenization for fluid and drug transport in vascularized malignant tissues
Penta, R., Ambrosi, D., & Quarteroni, A. M. (2014) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202515500037 · Cited by 92
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
Bian, X., Zhou, L., Luo, Z., Liu, G., Hang, Z., Li, H., Li, F., & Wen, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c11858 · Cited by 101
Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation
Tang, L., van de Ven, A. L., Guo, D., Andasari, V., Vittorio Cristini, C., Li, K. C., & Zhou, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083962 · Cited by 93
Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors
Cook, K. L., Metheny‐Barlow, L. J., Tallant, E. A., & Gallagher, P. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1136 · Cited by 92
Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
Lu, R., Chen, M., Chang, D.-K., Chiu, C., Lin, W.-C., Yan, S.-L., Wang, Y., Kuo, Y., Yeh, C.-Y., Lo, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066128 · Cited by 92
Stromal regulation of vessel stability by MMP14 and TGFβ
Sounni, N. E., Dehne, K., van Kempen, L. C. L. T., Egeblad, M., Affara, N. I., Cuevas, I., Wiesen, J. F., Junankar, S. R., Korets, L. V., Lee, J., et al. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003863 · Cited by 97
Jumping the barrier: VE‐cadherin, VEGF and other angiogenic modifiers in cancer
Le Guelte, A., Dwyer, J., & Gavard, J. (2011) · Biology of the Cell · doi:10.1042/bc20110069 · Cited by 91
Nanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery
Mirón-Barroso, S., Domènech, E. B., & Trigueros, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168537 · Cited by 91
Coaxial electrohydrodynamic atomization: Microparticles for drug delivery applications
Davoodi, P., Fěng, F., Xu, Q., Yan, W., Tong, Y. W., Srinivasan, M., Sharma, V. K., & Wang, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.004 · Cited by 91
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
Guo, Z. S., Liu, Z., Kowalsky, S. J., Feist, M., Kaliński, P., Lu, B., Storkus, W. J., & Bartlett, D. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00555 · Cited by 93
Non-viral based miR delivery and recent developments
Labatut, A. E., & Mattheolabakis, G. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.018 · Cited by 92
Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors
Islam, R., Maeda, H., & Fang, J. Q. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1874916 · Cited by 96
NIR Spectroscopic Detection of Breast Cancer
Nioka, S., & Chance, B. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400504 · Cited by 94
Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment
Belhadj, Z., Zhan, C., Man, Y. M., Wei, X., Xie, C., Yan, Z., & Lu, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17976 · Cited by 91
Pathways of chemotherapy resistance in castration-resistant prostate cancer
Mahon, K. L., Henshall, S. M., Sutherland, R. L., & Horvath, L. G. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0343 · Cited by 89
Nitric Oxide Releasing d -α-Tocopheryl Polyethylene Glycol Succinate for Enhancing Antitumor Activity of Doxorubicin
Song, Q., Tan, S., Zhuang, X., Guo, Y., Zhao, Y., Wu, T., Qi, Y., Si, L., & Zhang, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5003009 · Cited by 90
Functional Nanoparticles for Tumor Penetration of Therapeutics
Su, Y., & Hu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040193 · Cited by 91
Use of Oppositely Polarized External Magnets To Improve the Accumulation and Penetration of Magnetic Nanocarriers into Solid Tumors
Liu, J. F., Lan, Z., Ferrari, C., Stein, J. M., Higbee-Dempsey, E. M., Yan, L., Amirshaghaghi, A., Cheng, Z., Issadore, D., & Tsourkas, A. (2019) · ACS Nano · doi:10.1021/acsnano.9b05660 · Cited by 91
Active matter therapeutics
Ghosh, A., Xu, W., Gupta, N., & Gracias, D. H. (2020) · Nano Today · doi:10.1016/j.nantod.2019.100836 · Cited by 90
Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration
Guo, J. X., Zeng, H., & Chen, Y. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00014 · Cited by 91
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
Sun, B., Hyun, H., Li, L., & Wang, A. Z. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0424-4 · Cited by 91
Focused Ultrasound for Immunomodulation of the Tumor Microenvironment
Joiner, J. B., Pylayeva‐Gupta, Y., & Dayton, P. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901430 · Cited by 90
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
Tian, C., Zheng, S., Liu, X., & Kamei, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01552-0 · Cited by 95
Delivering metal ions by nanomaterials: Turning metal ions into drug-like cancer theranostic agents
Liu, C., Guo, L., Wang, Y., Zhang, J., & Fu, C. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215332 · Cited by 90
Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts
Qiu, Z.-W., Zhong, Y., Lu, Z., Yan, N., Kong, R., Huang, J., Li, Z.-F., Nie, J., Li, R., & Cheng, H. B. (2024) · ACS Nano · doi:10.1021/acsnano.4c01499 · Cited by 90
Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib
Grantab, R., & Tannock, I. F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-214 · Cited by 88
Development and aging of the lymphatic vascular system
González-Loyola, A., & Petrova, T. V. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.005 · Cited by 89
Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1
Akashi, Y., Oda, T., Ohara, Y., Miyamoto, R., Kurokawa, T., Hashimoto, S., Enomoto, T., Yamada, K., Satake, M., & Ohkohchi, N. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.49 · Cited by 89
Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy
Shamsi, M., Sedaghatkish, A., Dejam, M., Saghafian, M., Mohammadi, M., & Sanati‐Nezhad, A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1455764 · Cited by 91
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
Carceles‐Cordon, M., Kelly, W. K., Gomella, L. G., Knudsen, K. E., Rodríguez-Bravo, V., & Domenech, J. M. D. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0298-8 · Cited by 97
Bio-based nanomaterials for cancer therapy
Li, Y., Zheng, X., & Chu, Q. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101134 · Cited by 89
Multiparametric MRI for characterization of the tumour microenvironment
Hoffmann, E., Masthoff, M., Kunz, W. G., Seidensticker, M., Bobe, S., Gerwing, M., Berdel, W. E., Schliemann, C., Faber, C., & Wildgruber, M. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00891-1 · Cited by 103
Hyaluronan-Based Nanocarriers with CD44-Overexpressed Cancer Cell Targeting
Song, S., Qi, H., Xu, J., Guo, P., Chen, F., Li, F., Yang, X., Sheng, N., Wu, Y., & Pan, W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1393-4 · Cited by 89
Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells
Wu, X. G., Zhu, Y., Huang, W., Li, J., Zhang, B., Li, Z., & Yang, X. (2018) · Advanced Science · doi:10.1002/advs.201700859 · Cited by 89
Photoacoustic imaging as a tool to probe the tumour microenvironment
Brown, E. L., Brunker, J., & Bohndiek, S. E. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039636 · Cited by 87
Localized delivery of active targeting micelles from nanofibers patch for effective breast cancer therapy
Mehnath, S., Karuppannan, C., Karthikeyan, K., & Jeyaraj, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119412 · Cited by 88
TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma
Saccone, M. A., Soubeyran, P., Garcia, J., Audebert, S., Camoin, L., Rubis, M., Roques, J., Binétruy, B., Iovanna, J., & Tournaire, R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03920-4 · Cited by 95
Glycan Antagonists and Inhibitors: A Fount for Drug Discovery
Brown, J. R., Crawford, B. E., & Esko, J. D. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701751611 · Cited by 88
Matrix as an Interstitial Transport System
Dong, F., Creemers, E. E., & Kassiri, Z. (2014) · Circulation Research · doi:10.1161/circresaha.114.302335 · Cited by 91
Advances in the management of peritoneal malignancies
Képénékian, V., Bhatt, A., Péron, J., Alyami, M. S., Benzerdjeb, N., Bakrin, N., Falandry, C., Passot, G., Rousset, P., & Gléhen, O. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00675-5 · Cited by 87
Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan
Kohli, A. G., Kivimäe, S., Tiffany, M. R., & Szoka, F. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.019 · Cited by 88
Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy
Fang, K., Song, L., Gu, Z., Yang, F., Zhang, Y., & Gu, N. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.014 · Cited by 87
In vitromicrofluidic models of tumor microenvironment to screen transport of drugs and nanoparticles
Özçelikkale, A., Moon, H., Linnes, M. P., & Han, B. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1460 · Cited by 89
A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors
Stapleton, S., Milosevic, M., Allen, C. J., Zheng, J., Dunne, M., Yeung, I. W. T., & Jaffray, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081157 · Cited by 86
How to improve exposure of tumor cells to drugs — Promoter drugs increase tumor uptake and penetration of effector drugs
Marcucci, F., & Corti, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.007 · Cited by 90
Lipid-based nanosystems: the next generation of cancer immune therapy
Cheng, Z., Fobian, S., Gurrieri, E., Amin, M., D’Agostino, V., Falahati, M., Zalba, S., Debets, R., Garrido, M. J., Saeed, M., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01574-1 · Cited by 95
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex
Kato, M., Hattori, Y., Kubo, M., & Maitani, Y. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.015 · Cited by 85
Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft
Pan, A., Wang, Z., Chen, B., Dai, W., Zhang, H., He, B., Wang, X., Wang, Y., & Zhang, Q. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474971 · Cited by 85
The role of pancreatic stellate cells in pancreatic cancer
Moir, J. A. G., Mann, J., & White, S. A. (2015) · Surgical Oncology · doi:10.1016/j.suronc.2015.05.002 · Cited by 84
Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors
Saucier-Sawyer, J. K., Seo, Y.-E., Gaudin, A., Quijano, E., Song, E., Sawyer, A. J., Deng, Y., Huttner, A. J., & Saltzman, W. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.006 · Cited by 84
Soft Substrates Containing Hyaluronan Mimic the Effects of Increased Stiffness on Morphology, Motility, and Proliferation of Glioma Cells
Pogoda, K., Bucki, R., Byfield, F. J., Cruz, K., Lee, T., Marcinkiewicz, C., & Janmey, P. A. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00324 · Cited by 84
Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications
Jarak, I., Varela, C. L., da Silva, E. J. T., Roleira, F. M. F., Veiga, F., & Figueiras, A. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112526 · Cited by 83
Versatile Polymer‐Initiating Biomineralization for Tumor Blockade Therapy
Jiang, Z., Liu, Y., Shi, R., Feng, X., Xu, W., Zhuang, X., Ding, J., & Chen, X. (2022) · Advanced Materials · doi:10.1002/adma.202110094 · Cited by 84
Smart Lipid Nanoparticle that Remodels Tumor Microenvironment for Activatable H 2 S Gas and Photodynamic Immunotherapy
Wu, L., Liu, Y., Zeng, W., Ishigaki, Y., Zhou, S., Wang, X., Sun, Y., Zhang, Y., Jiang, X., Suzuki, T., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c11328 · Cited by 84
Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies
Couture, O., Foley, J. L., Kassell, N. F., Larrat, B., & Aubry, J. (2014) · Translational Cancer Research · doi:10.21037/3354 · Cited by 86
Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers
Tsvetkova, Y., Beztsinna, N., Baues, M., Klein, D. C. G., Rix, A., Golombek, S. K., Rawashdeh, W. A., Gremse, F., Barz, M., Koynov, K., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01171 · Cited by 86
High Pressure Enhances the Effect of Hyperthermia in Intraperitoneal Chemotherapy With Oxaliplatin
Facy, O., Samman, S. A., Magnin, G., Ghiringhelli, F., Ladoire, S., Chauffert, B., Rat, P., & Ortega‐Deballon, P. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e3182582b38 · Cited by 83
Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers
Raza, F., Zafar, H., You, X., Asifullah, K., Wu, J., & Ge, L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01842e · Cited by 85
Peptide-modulated self-assembly as a versatile strategy for tumor supramolecular nanotheranostics
Li, S., Zou, Q., Xing, R., Govindaraju, T., Fakhrullin, R. F., & Yan, X. (2019) · Theranostics · doi:10.7150/thno.31814 · Cited by 85
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
Maßgeschneiderte Nanopartikel für den Wirkstofftransport in der Krebstherapie
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Younan Xia, A. (2014) · Angewandte Chemie · doi:10.1002/ange.201403036 · Cited by 82
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors
Giordano, S., Morosi, L., Veglianese, P., Licandro, S. A., Frapolli, R., Zucchetti, M., Cappelletti, G., Falciola, L., Pifferi, V., Visentin, S., et al. (2016) · Scientific Reports · doi:10.1038/srep37027 · Cited by 83
Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule
Steuperaert, M., Labate, G. F. D., Debbaut, C., Wever, O. D., Vanhove, C., Ceelen, W. P., & Segers, P. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1269848 · Cited by 82
Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism
Sharma, A., Sinha, S., & Shrivastava, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.849040 · Cited by 85
Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules
Gonella, A., Grizot, S., Liu, F., Noriega, A. L., & Richard, J. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2105318 · Cited by 82
Rigid nanoparticle-based delivery of anti-cancer siRNA: Challenges and opportunities
Wang, Z., Liu, G., Zheng, H., & Chen, X. S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.020 · Cited by 83
The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas
Tascilar, M., Loos, W. J., Seynaeve, C., Verweij, J., & Sleijfer, S. (2007) · The Oncologist · doi:10.1634/theoncologist.12-11-1351 · Cited by 82
Liposomal Drug Delivery Systems for Targeted Cancer Therapy: Is Active Targeting the Best Choice?
Fathi, S., & Oyelere, A. K. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0135 · Cited by 83
In vivo cation exchange in quantum dots for tumor-specific imaging
Liu, X., Braun, G. B., Qin, M., Ruoslahti, E. I., & Sugahara, K. N. (2017) · Nature Communications · doi:10.1038/s41467-017-00153-y · Cited by 81
Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
Sharma, A., Sharma, R. B., Zhang, Z., Liaw, K., Kambhampati, S. P., Porterfield, J. E., Lin, K. C., DeRidder, L. B., Kannan, S., & Kannan, R. M. (2020) · Science Advances · doi:10.1126/sciadv.aay8514 · Cited by 85
Membrane Fluidity as a New Means to Selectively Target Cancer Cells with Fusogenic Lipid Carriers
Bompard, J., Rosso, A., Brizuela, L., Mebarek, S., Blum, L. J., Trunfio-Sfarghiu, A.-M., Lollo, G., Granjon, T., Girard-Egrot, A., & Maniti, O. (2020) · Langmuir · doi:10.1021/acs.langmuir.0c00262 · Cited by 84
Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
Wang, W., Zheng, H., Jiang, J., Li, Z., Jiang, D., Shi, X., Wang, H., Jiang, J., Xie, Q., Gao, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32066-w · Cited by 81
MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis
Sounni, N. E., Paye, A., Host, L., & Noël, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00111 · Cited by 82
A perfusable 3D cell–matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport
Ng, C. P., & Pun, S. H. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21698 · Cited by 81
Chemotherapy-Based Treatment for Castration-Resistant Prostate Cancer
Šeruga, B., & Tannock, I. F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.3996 · Cited by 83
Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs
He, H., Yuan, D., Wu, Y., & Cao, Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030110 · Cited by 80
Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis
Mihaljević, A. L., Michalski, C. W., Friess, H., & Kleeff, J. H. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0622-5 · Cited by 83
Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer
Moir, J., White, S., French, J., Littler, P., & Manas, D. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.08.480 · Cited by 80
Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics
Stapleton, S., Dunne, M., Milosevic, M., Tran, C. W., Gold, M. J., Vedadi, A., McKee, T. D., Ohashi, P. S., Allen, C. J., & Jaffray, D. A. (2018) · ACS Nano · doi:10.1021/acsnano.7b06301 · Cited by 81
The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin
Fan, Y., Du, W., He, B., Fu, F.-Y., Yuan, L., Wu, H., Dai, W., Zhang, H., Wang, X., Wang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.012 · Cited by 79
Clinical translation of immunoliposomes for cancer therapy: recent perspectives
Wang, D., Sun, Y., Liu, Y., Meng, F., & Lee, R. J. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517747 · Cited by 80
Charge reversal induced colloidal hydrogel acts as a multi-stimuli responsive drug delivery platform for synergistic cancer therapy
He, G., Chen, S., Xu, Y., Miao, Z., Ma, Y., Qian, H., Lü, Y., & Zha, Z. (2019) · Materials Horizons · doi:10.1039/c9mh00020h · Cited by 80
Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation
Olson, M. T., Ly, Q. P., & Mohs, A. M. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1239-2 · Cited by 79
Exosomic microRNAs in the Tumor Microenvironment
Neviani, P., & Fabbri, M. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00047 · Cited by 78
Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
Chen, W., Sun, Z., & Lu, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201914511 · Cited by 79
Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
Zhao, Y., Yu, X., & Li, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.014 · Cited by 81
Nanobubbles for therapeutic delivery: Production, stability and current prospects
Batchelor, D. V. B., Armistead, F. J., Ingram, N., Peyman, S. A., McLaughlan, J. R., Coletta, P. L., & Evans, S. D. (2021) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2021.101456 · Cited by 78
Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
Gong, J., Shi, T., Liu, J., Pei, Z., Liu, J., Ren, X., Li, F., & Qiu, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114505 · Cited by 83

Authors: Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A.
Affiliations: Ludwig Cancer Research (SE)
Uppsala University (SE)
University of California, San Francisco (US)
Karolinska Institutet (SE)
Corresponding author: Heldin, Carl-Henrik
ORCID: Heldin, Carl-Henrik
Rubin, Kristofer
Pietras, Kristian
Östman, Arne
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-10
Volume: 4
Issue: 10
Pages: 806-813
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1456
OpenAlex: W2028156849
Cited by: 2,222
References: 78
Citations by year: 2026: 121 · 2025: 110 · 2024: 118 · 2023: 119 · 2022: 163 · 2021: 158 · 2020: 158 · 2019: 123 · 2018: 123 · 2017: 135 · 2016: 133 · 2015: 110 · 2014: 117 · 2013: 124 · 2012: 87
FWCI: 3.19
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: Cancerfonden
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords: interstitial fluid pressure, solid tumors, tumor microenvironment, tumor fibrosis, anticancer drug delivery, tumor hypoxia
MeSH terms: Alprostadil, Animals, Antineoplastic Agents, Biological Transport, Bradykinin, Humans, Hyaluronoglucosaminidase, Hydrostatic Pressure, Neoplasms, Niacinamide, Platelet-Derived Growth Factor, Tumor Necrosis Factor-alpha, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Extracellular Fluid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks